DERMOVATE CREAM

15.75 EGP

Purchase this product now and earn 16 Points!

Description

DERMOVATE CREAM

clobetsol, anti inflammatory agents .

ACTIVE-INGREDIENT OF DERMOVATE CREAM

DERMOVATE CREAM and OINTMENT contains Clobetasol propionate 0.05 % w/w.

INDICATION OF DERMOVATE CREAM

  • DERMOVATE is a very potent topical corticosteroid indicated for adults,
  • elderly and children over 1 year for the relief of the inflammatory and pruitic manifestations of steroid responsive dermatoses.
  • These include the following: Psoriasis (excluding widespread plaque psoriasis).
  • Rcalcitrant dermatoses.
  • Lichen planus. Discoid lupus erythematosus.

Other skin conditions which do not respond satisfactorily to less potent steroids.

DOSAGE OF DERMOVATE CREAM

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

  • Ointments are specially appropriate for dry, lichenified or scaly lesions.
  • Creams are specially appropriate for moist or weeping surfaces.
  • Adults , elderly,and children over 1 year :
  • Apply thinly and gently rub in using only enough to cover the entire affected area once or twice a day for up to 4 weeks
  • until improvement occurs, then reduce the frequency of application or change the treatment to a less potent preparation.
  • Allow adequate time for absorption after each application before applying an emollient.
  • Repeated short courses of DERMOVATE may be used to control exacerbations.
  • In more resistant lesions, especially where there is hyperkeratosis, the effect of DERMOVATE can be enhanced, If necessary, by occluding the treatment area with polythene film.
  • Over night occulsion only is usually adequate to bring about a satisfactory response.
  • Thereafter improvement can usually be maintained by application without occlusion.
  • If the condition worsens or does not improve within 2 to 4 weeks, treatment and diagnosis should be re-evaluated.
  • Treatment should not be continued for more than 4 weeks.
  • If contiuous treatment is necessary, a less potent preparation should be used.
  • The maximum weekly dose should not exceed 50 gms/week.
  • Atopic dermatitis(eczema) : Therapy with DERMOVATE cream and ointment should be gradually discontinued once control is achieved and an emollient continued as maintenance therapy.
  • Rebound of pre-existing dermatoses can occur with abrupt discontinuation of DERMOVATE.
  • Recalcitrant dermatoses Ptients who frequently relapse : Once an acute episode has been treated effectively with a continous course of topical corticosteroids, intermittent dosing (once daily , twice weekly, without occlusion) may be considered.
  • This has been shown to be helpful in reducing the frequency of relapse.
  • Application should be continued to all previously affected sites or to known sites of potential relapse.
  • This regime should be combined with routine daily use of emollients.
  • The condition must be re-evaluated on a regular basis.
  • Children : DERMOVATE is contraindicated in children under one year of age.
  • Children are more likely to develop local and systemic side effects of topical corticosteroids and, in general, require shorter courses and less potent agents than adults.
  • Care should be taken when using DERMOVATE to ensure the amount applied is the minimum that provides therapeutic benefit.
  • Elderly : Clinical studies have not identified differences in responses between the elderly and younger patients.
  • The greater frequency of decreased hepatic or renal function in the elderly may delay elimination if systemic absorption ocuurs.
  • Therefore the minimum quantity should be used for the shortest duration to achieve the desired clinical benefit.

Renal/Hepatic Impairment: In case of systemic absorption (when application is over a large surface area for a prolonged period) metabolism and elimination may be delayed therefore the minimum quantity should be used for the shortest duration to achieve the desired clinical benefit.

OVER-DOSAGE OF DERMOVATE CREAM

Symptoms and signs:

Topically applied DERMOVATE may be absorbed in sufficient amounts to produce systemic effects.

Acute overdosage is very unlikely to occur, however, in the case of chronic overdoasge or misuse the features of hypercortisolism may appear (see Adverse Reactions).

Treatment : In the event of overdose, DERMOVATE should be withdrawn gradually by reducing the frequency of application, or by substituting a less potent corticosteroid because of the risk of glucocorticosteroid in sufficiency.

Further management should be as clinically indicated or as recommended by the national poisons centre, where available.

CONTRA-INDICATION OF DERMOVATE CREAM

The following conditions should not be treated with DERMOVATE: Untreated cutaneous infections. Rosacea. Acne vulgaris. Pruritus without inflammation. Perianal and genital pruritus. Perioral dermatitis. DERMOVATE is contraindicated in dermatoses in children under one year of age, including dermatitis .

STORAGE OF DERMOVATE CREAM

Store at temperature not exceeding 30 °C.
PACK OF DERMOVATE CREAM
Carton box containing 1 aluminum tube containing 25 gm cream & inner leaflet.
DERMOVATE CREAM MANUFACTURED BY
Smithkline Beecham -el haram – Giza. For : Glaxosmithkline S.A.E. – Egypt .

READ MORE

BUY FROM HERE

Additional information

Form

How to use

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “DERMOVATE CREAM”

Your email address will not be published.

Shopping Cart
Don`t copy text!
Scroll to Top
DERMOVATE CREAMDERMOVATE CREAM
15.75 EGP
Purchase this product now and earn 16 Points!